Inventor · disambiguated record
Yonghong Zhu
Also filed as: ZHU YONGHONG
19 granted patents·9 pending applications·95 citations·filing 2004–2024
92Inventor score
Top patents by PatentIndex Score
28 records- 0197USD959427SVR helmet accessoryZHU YONGHONG·Filed 2021·Granted Aug 2, 2022·53 cites·1 claims
- 0291USD962561SPet hair removerZHU YONGHONG·Filed 2021·Granted Aug 30, 2022·17 cites·1 claims
- 0387USD1058658SVirtual reality gogglesZHU YONGHONG·Filed 2024·Granted Jan 21, 2025·9 cites·1 claims
- 0481USD1032508SCharger for AR glassesZHU YONGHONG·Filed 2024·Granted Jun 25, 2024·6 cites·1 claims
- 0579US12090138B2Pharmaceutical composition containing silybin and VETASLY PHARMACEUTICAL GROUP CO·Filed 2022·Granted Sep 17, 2024·0 cites·8 claims
- 0676US8361515B2Extracts of Chenopodium ambrosioides L., the compositions comprising said extracts, the preparing process and application thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2006·Granted Jan 29, 2013·3 cites·20 claims
- 0766US9084755B2Method for extracting and separating ginkgolidesCHENGDU BAIYU TECHNOLOGY PHARMACY CO LTD·Filed 2014·Granted Jul 21, 2015·3 cites·15 claims
- 0866US8637092B2Pharmaceutical composition for treating diabetes and its process for preparationTONG XIAOLIN·Filed 2008·Granted Jan 28, 2014·2 cites·26 claims
- 0965US10307395B2Pharmaceutical composition containing silybin and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 1065US10307396B2Pharmaceutical composition containing silybin, VE and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 1161US10507197B2Pharmaceutical composition containing silibininTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Dec 17, 2019·0 cites·20 claims
- 1261US8586108B2Extracts of Chenopodium ambrosioides L., the compositions comprising said extracts, the preparing process and application thereofYE ZHENGLIANG·Filed 2012·Granted Nov 19, 2013·1 cites·23 claims
- 1360US11318112B2Pharmaceutical composition containing silybin and veTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted May 3, 2022·0 cites·18 claims
- 1460US10376491B2Pharmaceutical composition containing silibinin and pueraria root extractTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·20 claims
- 1560US2010158866A1Prediction of hcv treatment responseZHU YONGHONG·Filed 2009·Application pending·0 cites
- 1659US2023119360A1Pharmaceutical combination of a therapeutic oligonucleotide targeting hbv and a tlr7 agonist for treatment of hbvHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1758US2011195136A1Drop pill for treating coronary heart disease and preparation thereofCHEN JIANMING·Filed 2009·Application pending·0 cites
- 1857US10071989B2Substituted cinnamamide derivative, preparation method and use thereofMA XIAOHUI·Filed 2012·Granted Sep 11, 2018·1 cites·10 claims
- 1948US2013137084A1Single Nucleotide Polymorphism on Chromosome 15 That Predicts HCV Treatment ResponsesROCHE MOLECULAR SYSTEMS INC·Filed 2012·Application pending·0 cites
- 2048US2007059358A1Matrix adjuvants and the drop pills prepared with themTIANJIN TASLY PHARMACEUTICAL·Filed 2004·Application pending·0 cites
- 2143US2011281747A1Biomarkers for predicting rapid response to hcv treatmentCHIU SHU-HUI·Filed 2010·Application pending·0 cites
- 2242US2023044958A1Method of treating virus infection using a tlr7 agonistHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2341US9895405B2Use of radix salviae miltiorrhizae (danshen) or its preparations in preparation of drugs for treating diseases related to hepatic fibrosisTASLY PHARMACEUTICAL GROUP CO·Filed 2013·Granted Feb 20, 2018·0 cites·9 claims
- 2440US10874636B2Application of substituted cinnamamide derivatives in preparation of anti-anxiety medicationTASLY PHARMACEUTICAL GROUP CO·Filed 2017·Granted Dec 29, 2020·0 cites·9 claims
- 2539US2013078613A1Selection of HCV TreatmentIGLESIAS VICTOR·Filed 2012·Application pending·0 cites
- 2637US10376490B2Pharmaceutical composition containing silybinTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·17 claims
- 2736US2011312513A1Biomarkers for predicting sustained response to hcv treatmentCHIU SHU-HUI·Filed 2010·Application pending·0 cites
- 2832US10178091B2Method and router for accessing networkHUAWEI DEVICE SHENZHEN CO LTD·Filed 2014·Granted Jan 8, 2019·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →